ProMeris Duo


metaflumizone / amitraz

This medicine is now withdrawn from use in the European Union.


The marketing authorisation for ProMeris Duo has been withdrawn at the request of the marketing authorisation holder.

This EPAR was last updated on 13/07/2015

Authorisation details

Product details
ProMeris Duo
Agency product number
Active substance
  • metaflumizone
  • amitraz
International non-proprietary name (INN) or common name
  • metaflumizone
  • amitraz
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Pfizer Limited 
Date of issue of marketing authorisation valid throughout the European Union
Contact address
Pfizer Limited
Ramsgate Road
Kent CT13 9NJ
United Kingdom

Product information

08/07/2015 ProMeris Duo - EMEA/V/C/000108 - IB/0011

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Ectoparasiticides for topical use, incl. insecticides

Therapeutic indication

For the treatment and prevention of infestations by fleas (Ctenocephalides canis and C. felis), and ticks (Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus, Dermacentor reticulatus and Dermacentor variabilis), and treatment of demodicosis (caused by Demodex spp.) and lice (Trichodectes canis) in dogs.

The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

Assessment history

How useful was this page?

Add your rating